Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Business

Updated Consolidated Financial Forecasts and Introduction of Core-Based Financial Reporting

  • The Pharma Data
  • November 1, 2024

Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Toichi Takino; “the Company”) today announced that it has revised its consolidated financial forecasts for the full-year period ending March 2025 disclosed at…

Read MoreUpdated Consolidated Financial Forecasts and Introduction of Core-Based Financial Reporting
  • Press Releases

Halozyme Announces Q3 2024 Financial and Operational Results

  • The Pharma Data
  • November 1, 2024

Halozyme Therapeutics, Inc. (NASDAQ: HALO) released its third-quarter 2024 financial and operational results, showcasing strong revenue growth and notable corporate developments. CEO Commentary on Performance and Growth “Our third-quarter performance…

Read MoreHalozyme Announces Q3 2024 Financial and Operational Results
  • Press Releases

Blueprint Medicines Q3 2024 Results & Increased Full-Year Revenue Guidance for AYVAKIT®/AYVAKYT®

  • The Pharma Data
  • November 1, 2024

Blueprint Medicines Corporation (Nasdaq: BPMC) today announced its financial results and business highlights for the third quarter ended September 30, 2024, along with updated financial guidance. Strong AYVAKIT Performance and…

Read MoreBlueprint Medicines Q3 2024 Results & Increased Full-Year Revenue Guidance for AYVAKIT®/AYVAKYT®
  • News

Bachem’s Sustainable Approach to TIDES Manufacturing

  • The Pharma Data
  • November 1, 2024

The pharmaceutical industry is evolving toward sustainability, with increasing awareness of the need for eco-friendly practices. Therapeutic peptides and oligonucleotides (TIDES) present particular challenges due to their traditionally resource-heavy manufacturing…

Read MoreBachem’s Sustainable Approach to TIDES Manufacturing
  • News

18-Year-Old Pyry Shadows SVP of R&D for a Day: I Aspire to Make a Social Impact

  • The Pharma Data
  • November 1, 2024

Exciting, Challenging, and Insightful – This Is the Impression Pyry Simi, an 18-year-old from Tampere, Gained of the Pharmaceutical Industry After Spending a Day with Outi Vaarala, SVP of Innovative…

Read More18-Year-Old Pyry Shadows SVP of R&D for a Day: I Aspire to Make a Social Impact
  • Research

SkinSpirit and Allergan Aesthetics Team Up to Empower Girls Inc. and Women in STEM

  • The Pharma Data
  • October 30, 2024

In its sixth year of collaboration with Girls Inc., Allergan Aesthetics, a subsidiary of AbbVie, is pleased to welcome SkinSpirit, a leading provider of medical aesthetics and skincare, to its…

Read MoreSkinSpirit and Allergan Aesthetics Team Up to Empower Girls Inc. and Women in STEM
  • News

ScaleReady Awards G-Rex® Grant to Luminary Therapeutics

  • The Pharma Data
  • October 30, 2024

ScaleReady, in partnership with Wilson Wolf Manufacturing and Bio-Techne Corporation (NASDAQ: TECH), has announced that Luminary Therapeutics has been awarded a $300,000 G-Rex® Grant. This funding will facilitate rapid process…

Read MoreScaleReady Awards G-Rex® Grant to Luminary Therapeutics
  • Business

Viatris Recognized on Forbes’ 2024 List of World’s Top Companies for Women

  • The Pharma Data
  • October 30, 2024

Global healthcare company Viatris has been named to Forbes’ World’s Top Companies for Women 2024 list, an honor awarded in collaboration with Statista, a leading statistics and industry ranking provider.…

Read MoreViatris Recognized on Forbes’ 2024 List of World’s Top Companies for Women
  • Regulatory

Exelixis Reports Q3 2024 Financial Results and Corporate Update

  • The Pharma Data
  • October 30, 2024

Exelixis, Inc. (Nasdaq: EXEL) released its third-quarter financial results for 2024 and highlighted recent progress across key commercial, clinical, and pipeline milestones. Key Developments and Corporate Updates Pipeline and Clinical…

Read MoreExelixis Reports Q3 2024 Financial Results and Corporate Update
  • Press Releases

WHO Activates Global Health Emergency Corps for First Time in Response to Mpox Outbreak

  • The Pharma Data
  • October 30, 2024

In October 2024, the World Health Organization (WHO), alongside its partners and Member States, activated the Global Health Emergency Corps (GHEC) for the first time to support countries grappling with…

Read MoreWHO Activates Global Health Emergency Corps for First Time in Response to Mpox Outbreak
  • News

Tuberculosis Returns as Leading Infectious Disease Killer

  • The Pharma Data
  • October 30, 2024

The World Health Organization (WHO) has released its latest report on tuberculosis (TB), revealing that 8.2 million people were newly diagnosed in 2023—the highest number since WHO began tracking TB…

Read MoreTuberculosis Returns as Leading Infectious Disease Killer
  • Press Releases

Alliance for Transformative Action on Climate and Health Restructured at General Meeting

  • The Pharma Data
  • October 30, 2024

The Alliance for Transformative Action on Climate and Health (ATACH) recently held a virtual general meeting to announce a comprehensive restructuring aimed at enhancing its responsiveness to the climate crisis…

Read MoreAlliance for Transformative Action on Climate and Health Restructured at General Meeting
PrevNext
UK Biotech Day
Global Clinical
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Ono Pharma Files Approval Application in Japan for Ripretinib in Advanced Gastrointestinal Stromal Tumor
  • Neurocrine Biosciences Unveils First Expert Consensus Guidelines for Tardive Dyskinesia in Long-Term Care Settings
  • Allergan Aesthetics Introduces Next-Generation JUVÉDERM Hyaluronic Acid Injectables at AMWC Monaco
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.